A targeted antibody‑drug conjugate wipes out measurable residual disease in adult acute lymphoblastic leukemia, cutting ...

Anthracycline and cytarabine chemotherapy has been the backbone of induction chemotherapy for AML for more than 50 years. Advances in our understanding of leukemia biology and the development of ...

While patients with acute myeloid leukemia (AML) are routinely treated with chemotherapy and other cell-killing therapies, existing options do not lead to favorable clinical outcomes in all patients.

The primary treatment for acute lymphoblastic leukemia (ALL) is chemotherapy. People with ALL generally receive a combination of chemotherapy drugs over the course of a few years. ALL can grow rapidly ...

Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...

Treatment for Acute Lymphocytic Leukemia (ALL) primarily involves chemotherapy, divided into three phases: induction (to achieve remission), consolidation (to eliminate remaining cancer cells), and ...

One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy—and an aggressive type of blood cancer called acute myeloid leukemia (AML) is notorious for this.

Researchers from the University of Missouri School of Medicine found that a targeted gene therapy may make acute myeloid leukemia (AML) more sensitive to chemotherapy, while also protecting the heart ...

Oral chemotherapy can be a viable alternative to intravenous infusions, though it may have its own challenges, such as unpleasant taste. Taste alterations are common side effects of cancer treatments, ...